Evidence map›Paper›PMID 20087649›Full record

ArticleBreast cancer research and treatment2010

The small heat shock protein HspB2 is a novel anti-apoptotic protein that inhibits apical caspase activation in the extrinsic apoptotic pathway.

Shayna E Oshita, Feng Chen, Toni Kwan, Fruma Yehiely, Vincent L Cryns

Abstract read
In one paragraph

Article in Breast cancer research and treatment, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Transcriptional profiling revealsFrontiers in immunology · 2025
    Article
  3. Article
  4. Review
  5. Evaluation of the Small Heat Shock Protein Family MembersInternational journal of molecular sciences · 2023
    Article
  6. Review
  7. High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shayna E OshitaCell Death Regulation Laboratory, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Lurie 4-113, Feinberg School of Medicine, Northwestern University, 303 East Superior Street, Chicago, IL 60611, USA.
Feng Chen
Toni Kwan
Fruma Yehiely
Vincent L Cryns

Funding

TRAINING IN METABOLISM, DIABETES AND ENDOCRINOLOGYT32DK007169 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Joseph Bass · 1988 to 2026
$6.6M
Role of alphaB-Crystallin in Cancer Cell DeathR01CA097198 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CRYNS, VINCENT L. · 2003 to 2007
$1.0M
NCI NIH HHS R01 CA097198NCI NIH HHS R01CA097198NIDDK NIH HHS T32 DK007169NIDDK NIH HHS T32DK007169
6 · The paper itself

Abstract

Members of the conserved small heat shock protein (sHSP) family, such as αB-crystallin and Hsp27, are constitutively expressed in diverse malignancies and have been linked to several hallmark features of cancer including apoptosis resistance. In contrast, the sHSP HspB2/MKBP, which shares an intergenic promoter with αB-crystallin, was discovered as a chaperone of the myotonic dystrophy protein kinase and has not been previously implicated in apoptosis regulation. Here we describe a new function for HspB2 as a novel inhibitor of apical caspase activation in the extrinsic apoptotic pathway. Specifically, we demonstrate that HspB2 is expressed in a subset of human breast cancer cell lines and that ectopic expression of HspB2 in breast cancer cells confers resistance to apoptosis induced by both TRAIL and TNF-α. We also show that HspB2 inhibits the extrinsic apoptotic pathway by suppressing apical caspases-8 and 10 activation, thereby blocking downstream apoptotic events, such as Bid cleavage and caspase-3 activation. Consistent with these in vitro effects, HspB2 attenuates the anti-tumor activity of TRAIL in an orthotopic xenograft model of breast cancer. Collectively, our results reveal a novel function of HspB2 as an anti-apoptotic protein that negatively regulates apical caspase activation in the extrinsic apoptotic pathway.

Indexed as

ApoptosisAnimalsApoptosis Regulatory ProteinsBH3 Interacting Domain Death Agonist ProteinBreast NeoplasmsCaspase 3Caspase 8Cell Line, TumorDrug Resistance, NeoplasmEnzyme ActivationFemaleHSP27 Heat-Shock ProteinsHumansInjections, IntraperitonealMiceMice, NudeApoptosis Regulatory ProteinsBH3 Interacting Domain Death Agonist ProteinBID protein, humanCASP3 protein, humanCASP8 protein, humanCaspase 3Caspase 8HSP27 Heat-Shock ProteinsHSPB2 protein, humanTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alpha

Identifiers

PMID20087649
PMCPMC2956912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.